Neurodevelopmental outcomes in children with Down syndrome and congenital heart defects

Jeannie Visootsak1, William T Mahle, Paul M Kirshbom

  • 1Department of Human Genetics, Emory University, Atlanta, Georgia, USA. Jvisoot@emory.edu

Insights

Children with Down syndrome (DS) and congenital heart defects (CHD), specifically atrioventricular septal defects (AVSD), showed significant delays in motor development compared to those with DS but no heart issues. Early developmental trajectories in DS + AVSD require further investigation.

Area of Science:

  • Medical Genetics
  • Developmental Pediatrics
  • Pediatric Cardiology

Background:

  • Down syndrome (DS), caused by Trisomy 21, is the leading genetic cause of intellectual disability.
  • Congenital heart defects (CHD), particularly atrioventricular septal defects (AVSD), affect about half of children with DS.
  • Improved survival post-cardiac surgery necessitates understanding early development in DS with comorbid CHD.

Purpose of the Study:

  • To compare the early developmental trajectories of infants with DS and AVSD (DS + AVSD) to those with DS but no CHD (DS - CHD).
  • To identify potential differences in cognitive, language, and motor domains between these groups.

Main Methods:

  • Utilized the Bayley Scales of Infant and Toddler Development III for assessment.
  • Compared 12 infants with DS + AVSD against 17 infants with DS - CHD.
  • Analyzed developmental domains including cognitive, language, and motor skills.

Main Results:

  • The motor domain was the only area showing a statistically significant difference (P < 0.05) between the DS + AVSD and DS - CHD groups.
  • Cognitive standard scores (P = 0.63) and language composite scores (P = 0.10) were lower in the DS + AVSD group, though not statistically significant.
  • Mean ages of the cohorts were comparable (14.5 ± 7.3 months for DS + AVSD vs. 14.1 ± 8.4 months for DS - CHD).

Conclusions:

  • Infants with DS and AVSD may experience motor development delays compared to peers with DS but without CHD.
  • While not statistically significant in this cohort, trends suggest potential impacts on cognitive and language development.
  • These findings are crucial for clinicians providing anticipatory guidance for children with DS and comorbid congenital heart defects.

Related Concept Videos

Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by a...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...